Table 2.

Subset of RRMS patients with available MRI imaging data

Figure	Cohorts	Females	Age	Disease duration	EDSS	Treatment
4B and C	RRMS (46)	34 (73.9%)	42.6 [36.0: 49.8]	7.5 [3.3: 9.4]	1.9 [0.0: 2.09]	37 (80.4%)

‘Females’ indicates both the absolute count and percentage of females within the group. ‘Age’, ‘Disease duration’ and ‘EDSS’ are presented as mean values, with the 25th and 75th percentiles indicated in square brackets. ‘Treatment’ represents the absolute count and percentage of patients who received treatment, while specific individual treatments as well as individual information about MRI stability, lesion load volume change and white matter volume loss (WMVL) are listed in Supplementary Tables 2 and 3. No additional noteworthy comorbidities or pharmaceutical treatments were reported among the patients.